Cargando…

Optimal threshold of adherence to lipid lowering drugs in predicting acute coronary syndrome, stroke, or mortality: A cohort study

OBJECTIVE: Thresholds defining medication adherence are rarely evidence-based. A threshold of 0.8 is typically presumed to achieve improved outcomes. We aimed to assess the optimal threshold of adherence to lipid-lowering drugs (LLD) in predicting cardiovascular-related (CV) outcomes in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zongo, Arsène, Simpson, Scot, Johnson, Jeffrey A., Eurich, Dean T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760888/ https://www.ncbi.nlm.nih.gov/pubmed/31553787 http://dx.doi.org/10.1371/journal.pone.0223062

Ejemplares similares

Change in Trajectories of Adherence to Lipid‐Lowering Drugs Following Non‐Fatal Acute Coronary Syndrome or Stroke
por: Zongo, Arsène, et al.
Publicado: (2019)

Effect of a pharmacy comprehensive chronic diseases care plan on use of lipid-lowering drugs among patients with hypertension
por: Zongo, Arsène, et al.
Publicado: (2021)

The Darkening Cloud of Diabetes: Do trends in cardiovascular risk management provide a silver lining?
por: Eurich, Dean T., et al.
Publicado: (2008)

Medical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study
por: Zongo, Arsene, et al.
Publicado: (2021)

Substance Use Disorders and Psychoactive Drug Poisoning in Medically Authorized Cannabis Patients: Longitudinal Cohort Study
por: Zongo, Arsène, et al.
Publicado: (2021)

Renal effectiveness and safety of the sodium-glucose cotransporter-2 inhibitors: a population-based cohort study
por: Alkabbani, Wajd, et al.
Publicado: (2021)

Five comparative cohorts to assess the risk of genital tract infections associated with sodium‐glucose cotransporter‐2 inhibitors initiation in type 2 diabetes mellitus
por: Alkabbani, Wajd, et al.
Publicado: (2022)

Does the association between adherence to statin medications and mortality depend on measurement approach? A retrospective cohort study
por: Alsabbagh, Mhd. Wasem, et al.
Publicado: (2017)

Concurrent use of opioids and benzodiazepines/Z-drugs in Alberta, Canada and the risk of hospitalisation and death: a case cross-over study
por: Sharma, Vishal, et al.
Publicado: (2020)

Lower All-Cause Mortality for Coronary Heart or Stroke Patients Who Adhere Better to Mediterranean Diet-An NHANES Analysis
por: Liang, Kae-Woei, et al.
Publicado: (2022)

Anti-Hyperglycemic Medication Adherence and Health Services Utilization in People with Diabetes: A Longitudinal Study of Alberta’s Tomorrow Project
por: Ye, Ming, et al.
Publicado: (2022)

Use of Lipid-Lowering Medications and the Likelihood of Achieving Optimal LDL-Cholesterol Goals in Coronary Artery Disease Patients
por: Karalis, Dean G., et al.
Publicado: (2012)

Are Lipid-Lowering and Antihypertensive Medications Used as Complements to Heart-Healthy Diets? A Scoping Review
por: Desjardins, Clémence, et al.
Publicado: (2023)

Adherence to lipid-lowering treatment: the patient perspective
por: Casula, Manuela, et al.
Publicado: (2012)

Nonadherence to lipid‐lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease
por: Desai, Nihar R., et al.
Publicado: (2022)

Characterisation of concurrent use of prescription opioids and benzodiazepine/Z-drugs in Alberta, Canada: a population-based study
por: Sharma, Vishal, et al.
Publicado: (2019)

Adherence To Lipid-Lowering Therapy In Patients With Coronary Heart Disease From The State Of Saxony-Anhalt, Germany
por: Waßmuth, Stephan, et al.
Publicado: (2019)

Lipid-Lowering Therapy in Patients with Coronary Heart Disease and Prior Stroke: Mission Impossible?
por: Temporelli, Pier Luigi, et al.
Publicado: (2021)

Revisiting the internal consistency and factorial validity of the 8-item Morisky Medication Adherence Scale
por: Zongo, Arsène, et al.
Publicado: (2016)

Intensity of and Adherence to Lipid‐Lowering Therapy as Predictors of Major Adverse Cardiovascular Outcomes in Patients With Coronary Heart Disease
por: Mazhar, Faizan, et al.
Publicado: (2022)

Predicting falls-related admissions in older adults in Alberta, Canada: a machine-learning falls prevention tool developed using population administrative health data
por: Sharma, Vishal, et al.
Publicado: (2023)

Optimal systolic and diastolic blood pressure threshold that associated with lower risk of white matter hyperintensity progression
por: Liu, Sibo, et al.
Publicado: (2023)

Optimal lipid-lowering therapy in patients who were functionally deferred percutaneous coronary intervention
por: Abe, Takuro, et al.
Publicado: (2023)

Beyond Adherence Thresholds: A Simulation Study of the Optimal Classification of Longitudinal Adherence Trajectories From Medication Refill Histories
por: Allemann, Samuel S., et al.
Publicado: (2019)

Randomized Trial of a Pharmacist-Delivered Intervention for Improving Lipid-Lowering Medication Adherence among Patients with Coronary Heart Disease
por: Ma, Yunsheng, et al.
Publicado: (2010)

The Adherence Rate Threshold is Drug Specific
por: Stauffer, Melissa E., et al.
Publicado: (2017)

Histogram-derived modified thresholds for coronary artery calcium scoring with lower tube voltage
por: Kim, Sungwon, et al.
Publicado: (2021)

Adherence to Lipid-Lowering Treatment by Single-Pill Combination of Statin and Ezetimibe
por: Rea, Federico, et al.
Publicado: (2021)

Working towards a better understanding of type 2 diabetes care organization with First Nations communities: a qualitative assessment
por: Wozniak, Lisa A., et al.
Publicado: (2020)

Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study
por: Lau, Darren, et al.
Publicado: (2013)

Development and Validation of a Machine Learning Model to Estimate Risk of Adverse Outcomes Within 30 Days of Opioid Dispensation
por: Sharma, Vishal, et al.
Publicado: (2022)

Better Medications Adherence Lowers Cardiovascular Events, Stroke, and All-Cause Mortality Risk: A Dose-Response Meta-Analysis
por: Liu, Mengying, et al.
Publicado: (2021)

An intensive, structured, mobile devices-based healthcare intervention to optimize the lipid-lowering therapy improves lipid control after an acute coronary syndrome
por: Ruiz-Bustillo, Sonia, et al.
Publicado: (2022)

Exploring the impact of pharmacist comprehensive annual care plans on perceived quality of chronic illness care by patients in Alberta, Canada
por: Necyk, Candace, et al.
Publicado: (2021)

Utilization and adherence to guideline-recommended lipid-lowering therapy at an academic medical center
por: Alburikan, Khalid A., et al.
Publicado: (2017)

Optimal surgeon and hospital volume thresholds to reduce mortality and length of stay for CABG
por: Chou, Ying-Yi, et al.
Publicado: (2021)

The impact of lipid-lowering medications on coronary artery plaque characteristics
por: Pulipati, Vishnu Priya, et al.
Publicado: (2021)

Secondary Prevention in Lower Extremity Artery Disease Patients: Lipid-Lowering Therapy and Long-Term Guideline Adherence
por: Mueller, Linda, et al.
Publicado: (2022)

Associations of lipids and lipid-lowering drugs with risk of stroke: a Mendelian randomization study
por: Qin, Hao, et al.
Publicado: (2023)

The Role of Lipid-Lowering Treatment in the Secondary Prevention of Ischemic Stroke
por: Tsankof, Alexandra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vj0io9v9a0c45s0nt0dn38d10c